Brussels, 07/03/2013 (Agence Europe) - An inverted triangle will soon feature on the package leaflet of certain drugs sold on the EU market, in line with a legal action adopted by the European Commission on 7 March. This symbol will allow patients and healthcare professionals easily to identify drugs which are the subject of additional monitoring. The text accompanying it will also encourage them to notify any undesirable and unexpected side-effects by means of national notification systems....